Source-grounded facts extracted from BioScience Health Innovations, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
BioScience Health Innovations, Inc.: Amended Restated Certificate of Incorporation to effect a 4-for-1 reverse stock split, effective September 10, 2025 (effective 2025-09-10).
“On September 10, 2025, BioScience Health Innovations, Inc. (the “Company”) amended its Restated Certificate of Incorporation (the “Certificate of Incorporation”), to effect a reverse split of the Company’s common stock on the basis that 4 (four) such shares of common stock shall become 1 (one) share of common stock.”
BioScience Health Innovations, Inc. completed an acquisition involving Best Labs, Inc. for 34,371,100 shares of the Company’s common stock, representing approximately 85.39% of the issued and outstanding shares (closed 2023-03-10).
“2023 (the “ Closing ”). As a result of the Exchange Agreement Best became the wholly-owned subsidiary of the Company. Upon the Closing, the Company issued the Best shareholders 34,371,100 shares of the Company’s common stock, representing approximately 85.39% of the issued and outstanding shares of the Company’s common stock following Closing, in exchange for all”
Justin Earl resigned as Chief Executive Officer at BioScience Health Innovations, Inc..
“Justin Earl tendered his resignation as the sole officer of the Company.”
John Chymboryk was appointed as Director at BioScience Health Innovations, Inc..
“Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.”
Darren Lopez was appointed as Director at BioScience Health Innovations, Inc..
“Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.”
Darren Lopez was appointed as Chief Executive Officer at BioScience Health Innovations, Inc..
“Darren López was appointed as the Chief Executive Officer of the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.